MIRA
INFORM REPORT
|
Report Date : |
11.07.2007 |
IDENTIFICATION DETAILS
|
Name : |
HONG KONG CHINA SUN
PHARMACEUTICAL GROUP LTD. |
|
|
|
|
Registered Office : |
Unit 503, 5/F, |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
17-4-2002 |
|
|
|
|
Com. Reg. No.: |
793489 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Importing and exporting various raw material medicines. |
RATING & COMMENTS
|
MIRA’s Rating : |
Ca |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
name & address
HONG KONG CHINA SUN
PHARMACEUTICAL GROUP LTD.
UNIT 503, 5/F,
30 CANTON ROAD, TSIMSHATSUI,
KOWLOON, HK. (REGISTERED ADDRESS)
TEL 86 (0) 20-61176636
FAX 86 (0) 20-87551572
EXECUTIVE SUMMARY
INCORPORATION DATE : 17-4-2002 (REGISTERED IN
HK)
REGISTRATION NO. :
793489
REGISTERED LEGAL FORM : PRIVATE
LIMITED CO.
CHIEF EXECUTIVE : ZHOU WEN LEI (CHAIRMAN)
STAFF STRENGTH :
0 (IN
AUTHORIZED CAPITAL : $1,000,000 = 1,000,000 SHARES @
$1.-
PAID-UP CAPITAL
: $1,000,000
BUSINESS LINE :
TRADING OF OFFICE SUPPLIES
TURNOVER :
N/A
EQUITIES :
N/A
PAYMENT :
NOT YET DETERMINED
RECOMM.
MARKET CONDITION :
AVERAGE
FINANCIAL CONDITION :
N/A
OPERATIONAL TREND : N/A
GENERAL REPUTATION :
AVERAGE
EXCHANGE RATE :
HKD 7.63 = USD1 AS OF 2007-7-10
Adopted abbreviations:
ANS - amount not stated
NS - not stated
SC - subject company (the company inquired by you)
NA - not available
M - million
HKD –
SC is a private limited co. incorporated under co. file no. 793489 on
17-4-2002.
Details
of its incorporation information are shown to be as follows:
Authorized
capital :$1M divided into 1M shares @ $1.
Paid-up
capital :$1M
Shareholders/subscribers (as at
17-4-2007) Number
of shares held
- Zhou Wen Lei / NA / Chinese 500,000
/ Rm 3019, Chun Tung House, Tung Tau Estate,
- *Zhang Tongli / PCHNG04325082 / Chinese 500,000
Directors(as at 17-4-2007)
Name(s), ID/passport number & nationality Registered address
*Also
director
Current
search reveals certain material change or amendment of SC has been recorded
within the last 2 years & noted as follows:
Partial
change in SC's directorship is as follows:
Name(s)
of resigned director(s) Resignation
date
Zhou
Wen Lei
24-4-2007
Name(s)
of newly appointed director(s) Appointment date
Nil
Nil
SC is believed to be a family business while information regarding the
principals' background is not available.
Upon a current contact,
SC’s
principal declined to release any bank information.
This section will contain the civil litigations & winding-up petitions
filed against SC for the last 6 years (as stored in our database), and the
mortgage/charge filed by SC for the last 2 years. In
Civil
litigation/winding-up petitions : None in our
database.
Mortgage/charge
record(s) : None filed since
its incorporation date.
Overall payment appraisal:
( ) Excellent (
) Good ( ) Average
( ) Fair (
) Poor (X) Not yet determined
The appraisal serves as a reference to reveal SC's payments habits and
ability to pay. It is based on the 3
weighed factors: Trade payment
experience (through current enquiry with SC's suppliers), our delinquent
payment records and our debt collection record concerning SC.
Trade payment experience : SC did not provide any name of trade/service suppliers and we have no other sources to conduct the enquiry at present.
Delinquent
payment record : None in our database.
Debt
collection record : No overdue
amount owed by SC was placed to us for collection within the last 6 years.
Business categories:
SC is mainly engaged in importing and exporting various raw material medicines.
Principal purchases:
Major
types of sourcing : Office
supplies
Local--type
of suppliers : Exporters &
distributors
Buying
terms : Credit
of 30 days
Overseas--supplying
countries :
Buying
terms : T/T
Principal market:
Local--type
of customers : Manufacturers
Selling
terms : COD &
credit of 45 days
Overseas--buying
countries : N/A
Selling
terms : T/T
Total number of employees: None in HK.
SC is
known to have an office in
On the internet we find one telephone number
of this office:
86-20-61176636
We dialed the
number, and it was transferred to 86 20-61135690. A lady surnamed Wang answered
the phone. According to Ms. Wang, her office is only a contact point of HONG
KONG CHINA SUN PHARMACEUTICAL GROUP LTD in
The address client provided is:
17 Nanyuege No. 63 Linhe Xiheng Road,
According to Ms Wang, the
A visit to the premises at the heading business address by our field
reporter revealed the following:
The address is a commercial premise outside of which SC's name was not
seen on display. Instead, the following
co. names were seen on display:
- SBC International Ltd.
- Success Business Centre
The gross area of the premises is estimated at 3,500 square feet.
Condition inside the premises during our visit:
Office/factory outlay: Standard
The premise is occupied as office by SBC International Ltd. which is a business
centre. The said co. provides operational (like telephone, fax & office
equipment) & clerical support service to its clients each of whom usually
sub-leases a desk or a room as office there.
She confirmed that SC is one of the many cos. whose secretarial &
accounting affairs are being handled by them.
It is a general practice in
She had promised to pass our message & deliver our brochure &
questionnaire to SC's principal(s). However, we have not yet received any
reply.
Our current inquiry reveals that no such name as SC is registered as a current
user of local fixed line telephone companies.
Outside sources indicate that the contact information of SBC
International Ltd. is as follows:
- Tel: 852-27340418
A call was made to the said tel. no. 852-2734041, and we managed to
contact the unidentified female of the said co., but she refused disclosing any
information regarding SC.
Although SC was registered in
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)